Ldavid Md

Dr. Ldavid Md serves as the Chief Medical Officer at Corinth BioSciences, where he leverages his extensive background in clinical science and drug development to drive innovative solutions in the biopharmaceutical landscape. With over 101 publications to his name, Dr. Ldavid has transitioned from an accomplished academic physician to a pivotal figure in the realm of drug discovery, focusing on the establishment of anatomical biomarkers that are crucial for enhancing the drug development process. His expertise in advanced geometric morphometric-based mathematical techniques positions him at the forefront of developing automated platforms that optimize the capture of spatial and biological content from medical images.

At Corinth BioSciences, Dr. Ldavid is spearheading key projects aimed at creating mathematically-derived, qualified biomarkers and surrogate endpoints. These initiatives are designed to improve the efficacy resolution of proof-of-concept (POC) and pivotal trials, ultimately accelerating the pathway to market for new therapeutics. His substantial experience in clinical trials and drug safety, combined with a strong foundation in medical affairs, equips him to navigate the complexities of early-stage and mature biotech environments effectively.

Dr. Ldavid's analytical mindset, entrepreneurial spirit, and innovative approach are instrumental in fostering a culture of excellence within the organization. His role not only emphasizes the importance of rigorous scientific methodologies but also highlights the need for strategic collaboration across multidisciplinary teams to achieve successful outcomes in drug development. As a Top 20 Executive MBA graduate, he brings a unique blend of managerial acumen and scientific expertise, making him a key asset in Corinth BioSciences' mission to advance healthcare through groundbreaking research and development initiatives.